Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-08-06
1992-11-10
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549318, A61K 3134, C07D30733
Patent
active
051623684
ABSTRACT:
Butalactin, a compound of the formula I ##STR1## can be produced by cultivation of Streptomyces species Y-86,36923. Butalactin has an antibiotic activity.
REFERENCES:
patent: 4070480 (1978-01-01), Aldridge et al.
patent: 4145437 (1979-03-01), Aldridge et al.
patent: 4188331 (1980-02-01), Pernet et al.
"A New Inducer of Anthracycline Biosynthesis" from Streptomyces Viridochromogenes, The Journal of Antibiotics, vol. 35, No. 12, pp. 1722-1723.
Blumbach Jurgen
Chatterjee Sugata
Franco Christopher M. M.
Ganguli Bimal N.
Vijayakumar Erra K.
Hoechst Aktiengesellschaft
Ivy C. Warren
Owens Amelia A.
LandOfFree
Butalactin and its use as pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Butalactin and its use as pharmaceutical, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Butalactin and its use as pharmaceutical will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2293259